Novo Nordisk A/S: Diabetes Mellitus, Type 1 trials

The registry lists 226 Diabetes Mellitus, Type 1 studies with Novo Nordisk A/S as lead sponsor. 2 are open to participants now and 32 have results posted.

Phase 1 75Phase 2 8Phase 3 53Phase 4 12No phase 78(a study in two phases counts in both)

Studies

Page 3 of 3. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Human Insulin NPH and Insulin Aspart in Type 1 DiabetesCompletedNCT00597233Phase 4
• Efficacy and Safety of Insulin Detemir in Type 1 DiabetesCompletedNCT00595374Phase 3
• Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 DiabetesCompletedNCT00593255Phase 4
• Comparison of Glycemic Control Achieved With 2 Different NeedlesCompletedNCT00572052Phase 4
• Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 DiabetesCompletedNCT00571935Phase 4
• Comparison of Two Pen Systems in Patients With Diabetes Treated With InsulinCompletedNCT00569998Phase 3
• Evaluating the Use of Two Different Needles in Subjects With DiabetesCompletedNCT00569426Phase 4
• Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 DiabetesCompletedNCT00569400Phase 3
• Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 DiabetesCompletedNCT00567775Phase 2
• Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and AsthmaTerminatedNCT00523042Phase 3
• Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT00472953Phase 3
• Effect of Exercise on the Absorption of Inhaled Human Insulin in Subjects With Type 1 DiabetesCompletedNCT00419718Phase 1
• Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human InsulinCompletedNCT00410033Not applicable
• Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 DiabetesCompletedNCT00365170Phase 4
• Comparison of NovoFine® Needles (4 mm vs. 6 mm)CompletedNCT00343343Phase 2
• Safety and Efficacy of Inhaled Insulin in Type 1 DiabetesTerminatedNCT00322257Phase 3
• The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting InsulinsCompletedNCT00313742Phase 4
• Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 DiabetesCompletedNCT00312156Phase 3
• Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 DiabetesCompletedNCT00312104Phase 3
• Comparison of Insulin Detemir With NPH Insulin in Type 1 DiabetesCompletedNCT00184665Phase 3
• Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 DiabetesCompletedNCT00184639Phase 3
• Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 DiabetesCompletedNCT00117780Phase 4
• Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and AdolescentsCompletedNCT00097071Phase 3
• NovoLog Observation Trial in Subjects With Type 1 and Type 2 DiabetesCompletedNCT00095446Phase 4
• Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 DiabetesCompletedNCT00095082Phase 3
• Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric PopulationCompletedNCT00071448Phase 3